Stock Events

Stock Events

Bioventix 

GBX1,899.5
46
+GBX199.5+11.74% Today

Statistics

Day High
1,900
Day Low
1,700
52W High
3,020
52W Low
1,300
Volume
36,661.6
Avg. Volume
-
Mkt Cap
99.25M
P/E Ratio
11.43
Dividend Yield
8.82%
Dividend
167.6

Upcoming

9
APR
Dividend Ex
Decreased
 
24
APR
Dividend Payment
Decreased
 
6
NOV
Dividend Ex
Estimated
 
20
NOV
Dividend Payment
Estimated
 
9
APR 27
Dividend Ex
Estimated
 

Dividends

8.82%Dividend Yield
Apr 26
GBX70
Nov 25
GBX80
Apr 25
GBX70
Nov 24
GBX87
Apr 24
GBX68
10Y Growth
13.44%
5Y Growth
7.39%
3Y Growth
-0.44%
1Y Growth
N/A

Earnings

30MarExpected
Q4 2022
Q3 2023
Q4 2023
Q3 2024
Q4 2024
Q3 2025
Q4 2025
68.96
72.73
76.49
80.26
Expected EPS
N/A
Actual EPS
70.01395436160001

Financials

57.82%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.62BRevenue
1.52BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BVXP.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers diagnostic solutions and competes in the antibody space, overlapping with Bioventix's antibody development for diagnostics.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation, through its subsidiaries, provides professional, medical, industrial, and commercial products and services, including diagnostic solutions that compete with Bioventix.
Resmed
RMD
Mkt Cap32.71B
ResMed Inc. specializes in medical devices for respiratory disorders but also ventures into health diagnostics, indirectly competing with Bioventix's diagnostic technologies.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, directly competing with Bioventix in the diagnostics sector.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Bioventix in the diagnostics and research market.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics market alongside Bioventix.
Bruker
BRKR
Mkt Cap5.6B
Bruker Corporation designs, manufactures, and distributes scientific instruments and analytical and diagnostic solutions, competing with Bioventix in the diagnostics and analytical solutions sector.
Waters
WAT
Mkt Cap29.85B
Waters Corporation produces analytical instruments, software, and services for the healthcare sector, including diagnostics, competing with Bioventix in the development of diagnostic solutions.
Agilent Technologies
A
Mkt Cap32.66B
Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, competing with Bioventix in the diagnostics and research fields.

About

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Show more...
CEO
Mr. Peter John Harrison MA
Employees
12
Country
GB
ISIN
GB00B4QVDF07

Listings

OTC Link
US
BVNXF
F
DE
51B.F
LSE
GB
BVXP.LSE

0 Comments

Share your thoughts

FAQ

What is Bioventix stock price today?▼
The current price of BVXP.LSE is GBX1,899.5 GBX — it has increased by +11.74% in the past 24 hours. Watch Bioventix stock price performance more closely on the chart.
What is Bioventix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioventix stocks are traded under the ticker BVXP.LSE.
Is Bioventix stock price growing?▼
BVXP.LSE stock has risen by +16.89% compared to the previous week, the month change is a +20.45% rise, over the last year Bioventix has showed a -25.22% decrease.
What is Bioventix market cap?▼
Today Bioventix has the market capitalization of 99.25M
When is the next Bioventix earnings date?▼
Bioventix is going to release the next earnings report on October 26, 2026.
What were Bioventix earnings last quarter?▼
BVXP.LSE earnings for the last quarter are 70.01 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Bioventix revenue for the last year?▼
Bioventix revenue for the last year amounts to 2.62B GBX.
What is Bioventix net income for the last year?▼
BVXP.LSE net income for the last year is 1.52B GBX.
Does Bioventix pay dividends?▼
Yes, BVXP.LSE dividends are paid semi-annual. The last dividend per share was 80 GBX. As of today, Dividend Yield (FWD)% is 8.82%.
How many employees does Bioventix have?▼
As of April 08, 2026, the company has 12 employees.
In which sector is Bioventix located?▼
Bioventix operates in the Health Care sector.
When did Bioventix complete a stock split?▼
Bioventix has not had any recent stock splits.
Where is Bioventix headquartered?▼
Bioventix is headquartered in Farnham, GB.